<DOC>
	<DOCNO>NCT01926626</DOCNO>
	<brief_summary>The propose study ass efficacy moclobemide , selective , reversible MAO-A inhibitor , facilitate smoke cessation treatment-seeking female smoker . This rationale base several finding previous work : 1 ) cigarette smoke contain constituent inhibit form enzyme monoamine oxidase ( MAO-A MAO-B ) ; 2 ) severity depression symptom smoke abstinence correlate level MAO-A inhibition previously obtain smoking ; 3 ) moclobemide , MAO-A inhibitor find efficacious smoke cessation treatment trial ( Berlin et al. , 1995 ) ; 4 ) woman show great association smoke depression men woman smoker previous trial report smoke alleviate symptom depression great extent men .</brief_summary>
	<brief_title>Evaluation Moclobemide , Reversible MAO-A Inhibitor , Adjunct Nicotine Replacement Therapy Female Smokers</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Moclobemide</mesh_term>
	<criteria>Have know serious medical condition ; Female ; Are 1865 year old ; Smoke average least 20 cigarette per day ; Have smoke least one cumulative year ; Have Fagerstrom Test Nicotine Dependence score least 5 ; Have expire air carbon monoxide ( CO ) reading least 10ppm ; Able read understand English ; Express desire quit smoke next thirty day . Potential subject must agree avoid follow participation study : excessive alcohol consumption ; use antidepressant ; general anesthesia ; participation nicotinerelated modification strategy outside protocol ; use tobacco product cigarette , include pipe tobacco , cigar , ecigarettes , snuff , chew tobacco ; use experimental ( investigational ) drug device ; use illegal drug ; cimetidine ; Tyramine rich food ; use opiate medication . Hypertension ; Hypotension symptom ; Coronary heart disease ; Lifetime history heart attack ; Cardiac rhythm disorder ; Chest pain ; Cardiac ( heart ) disorder ; Active skin disorder ; Liver kidney disorder ; Gastrointestinal problem disease gastroesophageal reflux heartburn ; Active ulcer past 30 day ; Currently Symptomatic lung disorder/disease ; Brain abnormality ; Migraine headaches occur frequently per week ; Recent , unexplained fainting spell ; Problems give blood sample ; Diabetes ( unless control diet exercise alone ) ; Current cancer treatment cancer past six ; Other major medical condition ; Current psychiatric disease ; Suicidal ideation ( within past 10 year ) lifetime occurrence attempt suicide ; Current depression ; Bulimia anorexia ; Use ( within past 45 day ) psychiatric medication include antidepressant antipsychotic ; Use ( within past 30 day ) : Illegal drug ( urine drug screen positive tetrahydrocannabinol ( THC ) , Cocaine , Amphetamine , Opiates , Methamphetamines , phencyclidine ( PCP ) , Benzodiazepines , Barbiturates ) , Experimental ( investigational ) drug ; Any medication know affect smoking cessation ( e.g . clonidine ) ; Smokeless tobacco ( chew tobacco , snuff ) , pip ecigarettes ; Wellbutrin , bupropion , Zyban , Chantix , nicotine replacement therapy smoke cessation aid . Use opiate medication pain sleep ( nonopiate medication pain sleep allow ) within past 14 day ; Smokes one cigar month . Alcohol abuse ; Significant adverse reaction nicotine patch , past . Known hypersensitivity moclobemide MAOA inhibitor . Current participation recent participation ( past 30 day ) another smoking study center another research facility . Current participation recent participation ( past six month ) another medical research study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Nicotine addiction</keyword>
	<keyword>Smoking Cessation</keyword>
	<keyword>Quit Smoking</keyword>
	<keyword>moclobemide</keyword>
	<keyword>Nicotine Patch</keyword>
</DOC>